Source: Wikimedia Commons .How can you know when Wall Street really loves a stock? One key sign is how many of the analysts covering the stock maintain buy ratings. Another tell-tale indicator is the price targets these analysts give for the stock. The higher the target is above the current share price, the more highly the analysts view the stock.Analysts […]
In a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as data from a phase II trial of MultiStem treatment one to two […]
Read the article:
Biotech Stock Boom
See which stocks are being affected by Social Media
[…]
View photo.Short interest among leading biotechs and emerging pharmaceuticals increased nearly all across the board between February 13 and February 27.Leading the trend were BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Celgene Corporation (NASDAQ: CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Here, Benzinga takes a quick look at how the stocks have fared recently and what analysts expects from them, followed by a […]
Biotech stocks are known for their wild ways. Over the last few years, for instance, we have witnessed dozens of small-cap companies soar — as well as sink — following pivotal clinical or regulatory catalysts.Perhaps one of the most intriguing aspects of this phenomenon is that the biggest moves tend to occur in under-the-radar biotechs. Before skyrocketing by over 300% […]
View gallery.When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of […]
“Our life is March weather, savage and serene in one hour.” — Ralph Waldo Emerson
Substitute “biotechs” for “our life” and you have the investing version of Emerson’s quote. Depending on how binary events go, they can certainly become savage or serene quite quickly.We asked our team of experts for their top biotech picks to watch this month. Read below to […]
NEW YORK (MarketWatch) — The current bull market is marking its sixth birthday, and a few slices of the stock market have more reason to celebrate than others.Who really deserves to whoop it up? Biotech and pharma ETFs, value ETFs that aim to find bargains, and ETFs targeting consumer-discretionary or retail stocks.The 10 ETFs that have performed best since the […]
Source: Flickr user stockmonkeys.com.Investing in clinical-stage biotech stocks isn’t for the faint of heart. The industry’s jaw-dropping pops and drops can be so dramatic as to suit these stocks only the most speculative portion of an investor’s portfolio.However, for investors willing to accept the risk of buying little-known biotech stocks such as Ophthotech , Portola Pharmaceuticals , and Insys Therapeutics […]
The biotech sector has the potential for outsized returns, but also extra risk not seen with larger pharmaceutical companies (and larger companies in general).Sometimes the easiest way to make money is to follow Warren Buffett’s advice and not lose it in the first place. We asked some of The Motley Fool’s biotech experts to weigh in on common mistakes investors […]
